Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zoetis    ZTS

ZOETIS

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/13/2021 01/14/2021 01/15/2021 01/19/2021 01/20/2021 Date
161.95(c) 160.96(c) 161.56(c) 162.57(c) 163.36(c) Last
2 603 060 2 213 940 2 516 495 1 464 165 1 617 993 Volume
-2.51% -0.61% +0.37% +0.63% +0.49% Change
More quotes
Financials (USD)
Sales 2020 6 600 M - -
Net income 2020 1 645 M - -
Net Debt 2020 3 277 M - -
P/E ratio 2020 48,1x
Yield 2020 0,48%
Sales 2021 7 113 M - -
Net income 2021 1 865 M - -
Net Debt 2021 2 436 M - -
P/E ratio 2021 41,0x
Yield 2021 0,60%
Capitalization 77 640 M 77 640 M -
EV / Sales 2020 12,3x
EV / Sales 2021 11,3x
Nbr of Employees 10 600
Free-Float 94,6%
More Financials
Company
Zoetis specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (50.2%): cats and dogs (93.8% of net sales) and horses (6.2%); - livestock (48.4%): cattle (54.6% of sales), swine (20.2%), poultry (18.4%), fish (4.4%) and other (2.4%); - other (1.4%). Net sales break down by family of products into vaccines (23.7%), antiinfectives (20%),... 
More about the company
Notations Surperformance© of Zoetis
Trading Rating : Investor Rating :
More Ratings
All news about ZOETIS
01/19INSIDER TRENDS : Zoetis Insider Converts Option/Derivative Security Sells Portio..
MT
01/08Credit Suisse Says Positive Developments in Healthcare 'Underappreciated'; To..
MT
2020ZOETIS : to Host Webcast and Conference Call on Fourth Quarter and Full Year 202..
BU
2020ZOETIS : Standing Out from the Crowd
PU
2020ZOETIS : to Participate in the 39th Annual J.P. Morgan Healthcare Conference
BU
2020ZOETIS : Raises Quarterly Dividend 25%
DJ
2020ZOETIS INC. : Change in Directors or Principal Officers, Regulation FD Disclosur..
AQ
2020Zoetis Hikes Quarterly Dividend to $0.25 per share From $0.20 per Share, Paya..
MT
2020ZOETIS : Declares First Quarter 2021 Dividend; Board Approves 25% Payment Increa..
BU
2020ZOETIS : Appoints Tonie Leatherberry to Its Board of Directors
BU
2020ZOETIS : Kristin Peck Named a Fortune BusinessPerson of the Year
PU
2020ZOETIS : Named One of the “Top 75 Companies for Executive Women” by ..
BU
2020Insider Selling at Zoetis (ZTS) Continues with Significant Sale
MT
2020ZOETIS : Researchers and Scientists Present at 6th World One Health Congress
PU
2020INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Zoetis
MT
More news
News in other languages on ZOETIS
2020EN DIRECT DES MARCHES : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa,..
2020Insoutenable
2020ZOETIS : publication des résultats trimestriels
2020ZOETIS : Veröffentlichung des Quartalsergebnisses
2020Il va y avoir comme un problème
More news
Analyst Recommendations on ZOETIS
More recommendations
Chart ZOETIS
Duration : Period :
Zoetis Technical Analysis Chart | ZTS | US98978V1035 | MarketScreener
Technical analysis trends ZOETIS
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 180,88 $
Last Close Price 163,36 $
Spread / Highest target 28,6%
Spread / Average Target 10,7%
Spread / Lowest Target -23,5%
EPS Revisions
Managers and Directors
NameTitle
Kristin C. Peck Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Roxanne Lagano Chief Human Resources Officer
Glenn C. David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS-1.29%77 640
ELANCO ANIMAL HEALTH INCORPORATED1.11%14 634
DECHRA PHARMACEUTICALS PLC6.20%5 405
JINYU BIO-TECHNOLOGY CO., LTD.-5.12%3 536
VIRBAC-7.98%2 235
VÉTOQUINOL SA9.33%1 308